The author reflects on the drug bioavailability and treatments for posterior ocular disease. He states that the posterior diseases including diabetic retinopathy, glaucoma, and retinitis pigmentosa causes irreversible blindness. He mentions that frequent delivery of drug from topical route to meet the therapeutic level may cause drug-related toxicities and side effects.